NAVB
Navidea Biopharmaceuticals Inc.
NAVB
NAVB
Delisted
NAVB was delisted on the 5th of October, 2023.
31 hedge funds and large institutions have $3.13M invested in Navidea Biopharmaceuticals Inc. in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 11 increasing their positions, 5 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less call options, than puts
Call options by funds: $ | Put options by funds: $
50% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 8
Holders
31
Holding in Top 10
–
Calls
$385K
Puts
$566K
Top Buyers
| 1 | +$75.1K | |
| 2 | +$54.4K | |
| 3 | +$47.3K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$44K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$40.2K |
Top Sellers
| 1 | -$266K | |
| 2 | -$183K | |
| 3 | -$75.6K | |
| 4 |
Squarepoint
New York
|
-$58K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$40.4K |